Literature DB >> 11514706

Sleep apnoea and hypertension: proof at last?

J R Stradling1, J C Pepperell, R J Davies.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11514706      PMCID： PMC1765982     

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  55 in total

1.  Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men.

Authors:  J R Stradling; J H Crosby
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

2.  The relation between snoring and smoking, body mass index, age, alcohol consumption and respiratory symptoms.

Authors:  F Kauffmann; I Annesi; F Neukirch; M P Oryszczyn; A Alpérovitch
Journal:  Eur Respir J       Date:  1989-07       Impact factor: 16.671

Review 3.  Sleep apnoea and systemic hypertension.

Authors:  J R Stradling
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

4.  Dippers and non-dippers.

Authors:  E O'Brien; J Sheridan; K O'Malley
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

5.  Walking 10,000 steps/day or more reduces blood pressure and sympathetic nerve activity in mild essential hypertension.

Authors:  M Iwane; M Arita; S Tomimoto; O Satani; M Matsumoto; K Miyashita; I Nishio
Journal:  Hypertens Res       Date:  2000-11       Impact factor: 3.872

6.  Daytime hypertension in obstructive sleep apnea. Prevalence and contributing risk factors.

Authors:  R P Millman; S Redline; C C Carlisle; A R Assaf; P D Levinson
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

7.  Evening-to-morning blood pressure variations in snoring patients with and without obstructive sleep apnea.

Authors:  V Hoffstein; J Mateika
Journal:  Chest       Date:  1992-02       Impact factor: 9.410

8.  The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome.

Authors:  R J Davies; J R Stradling
Journal:  Eur Respir J       Date:  1990-05       Impact factor: 16.671

Review 9.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

10.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321
View more
  3 in total

1.  Caffeine levels following treatment of obstructive sleep apnoea.

Authors:  G V Robinson; J C Pepperell; R J O Davies; J R Stradling
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

Review 2.  Meta-analysis of randomised controlled trials of oral mandibular advancement devices and continuous positive airway pressure for obstructive sleep apnoea-hypopnoea.

Authors:  Linda D Sharples; Abigail L Clutterbuck-James; Matthew J Glover; Maxine S Bennett; Rebecca Chadwick; Marcus A Pittman; Timothy G Quinnell
Journal:  Sleep Med Rev       Date:  2015-05-30       Impact factor: 11.609

3.  Obstructive sleep apnea presenting as pseudopheochromocytoma.

Authors:  Hela Marmouch; Sondes Arfa; Sameh Graja; Tensim Slim; Ines Khochtali
Journal:  Pan Afr Med J       Date:  2016-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.